top of page
  • Amazon
  • Youtube
  • TikTok
  • Facebook
  • Instagram
Copy of kindle cover.jpg

WE'RE BUILDING A FIRST OF ITS KIND OBESITY MEDICINE NEWS PLATFORM

SIGN UP FOR FREE HERE TO GET DAILY UPDATES FROM ON THE PEN! NEVER MISS A HEADLINE!

Microdosing and Off-Ramping GLP-1s: Questions You’ve Been Asking, Answers You Need to Hear

For months, I have been flooded with questions from the community.


Can I microdose my GLP-1 to save money and still keep the weight off?Is there a safe way to stop the medication without gaining everything back?


These are not questions asked in passing. They come from people who are staring down the cost of their next refill, feeling the side effects of a higher dose, or wondering if they are ready to step away from the needle. The answers are not simple, and most of the time, the people making decisions about our care are not living in these bodies or walking in our shoes.


In this conversation, I sat down with Noom CEO Geoff Cook to get another perspective on the two biggest topics in our space right now: microdosing and off-ramping GLP-1s.




We talked about:


  • What microdosing looks like from the Noom perspective

  • Whether gradually lowering your dose can help maintain weight loss

  • The role of behavioral support when stepping down or stopping treatment

  • Why there is such a gap between what patients are trying and what is in the studies


My goal was to bring you information from someone with a seat at a very big table in the weight loss world so you can make informed decisions about your own journey.


If you are considering microdosing, tapering, or stopping your GLP-1 entirely, I encourage you to watch this conversation. Not because it has all the answers, but because it might give you the right questions to ask your care team before you make a move.


Stay tuned to OnThePen.com for more updates and in-depth analysis on the latest developments in weight loss and diabetes treatments. Sharing this article is a powerful form of advocacy that brings us closer to our goal of educating the masses and reducing the stigma of obesity. If you found this piece helpful, share it in your Facebook groups, Reddit forums, or with someone you know who is navigating GLP-1 treatment decisions.




Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating
bottom of page